SCHEMBL13825577

SCHEMBL13825577

NC[C@H](NC(=O)c1ccc(-c2ccc(NC(=O)CN3CCC(C(=O)O)CC3)cc2)cc1)C(=O)NO

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.48
SMYD3 Q9H7B4 1/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
LMNA P02545 3/20 0.47
HTT P42858 2/20 0.47
ALDH1A1 P00352 2/20 0.44
TDP1 Q9NUW8 2/20 0.43
POLB P06746 2/20 0.43
MAPT P10636 1/20 0.43
MAPK1 P28482 1/20 0.43
TPSAB1 Q15661 2/20 0.42
TPSD1 Q9BZJ3 2/20 0.42
TPSG1 Q9NRR2 2/20 0.42
MEN1 O00255 4/20 0.41
KMT2A Q03164 4/20 0.41
GAA P10253 2/20 0.41
KDM4E B2RXH2 1/20 0.40
NPC1 O15118 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1912174 0.93 SMYD3 (0.58) L3MBTL1SMYD3SMN1; SMN2LMNAHTT
SCHEMBL13818620 0.92 L3MBTL1 (0.46) L3MBTL1SMYD3SMN1; SMN2LMNAHTT
SCHEMBL1109491 0.88 NPC1 (0.52) L3MBTL1SMN1; SMN2LMNAHTTALDH1A1
SCHEMBL1109204 0.88 DRD4 (0.48) L3MBTL1SMYD3SMN1; SMN2LMNAALDH1A1
SCHEMBL1109140 0.87 NPC1 (0.51) L3MBTL1SMN1; SMN2HTTALDH1A1TDP1
SCHEMBL1109363 0.87 NPC1 (0.51) L3MBTL1SMN1; SMN2HTTALDH1A1TDP1
SCHEMBL10285902 0.87 L3MBTL1 (0.41) L3MBTL1SMYD3SMN1; SMN2LMNAHTT
SCHEMBL1109391 0.85 ATM (0.51) SMN1; SMN2LMNAALDH1A1TDP1KDM4E
SCHEMBL1109490 0.85 CTSK (0.42) L3MBTL1SMN1; SMN2HTTALDH1A1TDP1
SCHEMBL1109173 0.85 ATM (0.51) SMN1; SMN2LMNAALDH1A1TDP1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090163496-A1 ANTIBACTERIAL AGENTS UNIVERSITY OF WASHINGTON (US) 2009-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090163496-A1 ANTIBACTERIAL AGENTS MRPL21, SI, PGLS L3MBTL1 2665/4885SMYD3 4769/4885SMN1; SMN2 2296/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.